EP3122426

DUKE UNIVERSITY
Application Number
EP15769394A
Filing Date
Mar 28, 2015
Status
Granted And Under Opposition
Dec 16, 2022
Grant Date
Jan 18, 2023
External Links
Slate, Register

Biblio Summary

The patent EP3122426B1 was granted on Jan 18, 2023 by Duke University The patent is currently Granted And Under Opposition.

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SANDOZOct 18, 2023ADMISSIBLE
TEVAOct 4, 2023ADMISSIBLE

The table below shows the patents of Duke University that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3823992Anti-Lypd3 Car T-Cell Therapy For The Treatment Of CancerDec 13, 20231
EP3773486Methods Of Treating Autism Spectrum Disorders Using Human Umbilical Cord Tissue-Derived Mesenchymal Stromal CellsDec 6, 20231
EP3360979Tert Promoter Mutations In Gliomas And A Subset Of TumorsMay 20, 20201